Application of Laparoscopy in Comprehensive Staging Operation of Ovarian Cancer Based on Electronic Medical Blockchain Technology

Ovarian cancer has always entangled most women. Studies have shown that the prevalence of ovarian cancer ranks third in female reproductive malignancies, and the mortality rate has always been the highest. The reason is mainly because the diagnosis and treatment of preovarian cancer has always been a big problem. However, the emergence of laparoscopy can well solve this problem, especially laparoscopy assisted by blockchain technology, which plays a huge role in the overall staging of ovarian cancer. This article proposes the application research of laparoscopy in the comprehensive staging of ovarian cancer based on electronic medical blockchain technology. First of all, this article uses the literature method to study the clinical characteristics and surgical classification of ovarian cancer, as well as the application status of blockchain technology and laparoscopic technology. Secondly, it designed an application experiment based on electronic medical blockchain technology to assist laparoscopy in the comprehensive staging of ovarian cancer and analyzed the comparison of the laparoscopic group and the control group in the comprehensive staging of ovarian cancer. The results of the study showed that the amount of bleeding in the laparoscopic group was 103.5 ml, while the amount of bleeding in the control group was 141.1 ml; the proportion of tertiary pain in the laparoscopic group was 11.37%, and the proportion of tertiary pain in the control group was 31.82%. From this, it can be seen that, in the comprehensive staging operation for ovarian cancer, the laparoscopic group has less intraoperative blood loss than the control group and lower pain, and the treatment effect is better.

Bilateral Ovarian Transitional Cell Carcinoma

ABSTRACT Ovarian cancer accounts for 6% of all cancers among women. The majority (85–90%) of malignant ovarian tumors are epithelial. Transitional cell carcinoma (TCC) has been described as a primary ovarian carcinoma in which definite urothelial features are present, but no benign, metaplastic, and/or proliferating Brenner tumor can be identified. It accounts for 1 to 2% of all ovarian tumors. Bilateral involvement is still rare. It is reported to be chemosensitive and has better prognosis than other types of common epithelial tumors of the ovary. Here, we report a rare case of bilateral TCC of the ovary managed by staging operation, followed by postoperative chemotherapy. How to cite this article Bannur HB, Suranagi VV, Davanagere R, Pilli GS. Bilateral Ovarian Transitional Cell Carcinoma. J South Asian Feder Menopause Soc 2017;5(1):69-70.

Bilateral Ovarian Transitional Cell Carcinoma

ABSTRACT Ovarian cancer accounts for 6% of all cancers among women. The majority (85—90%) of malignant ovarian tumors are epithelial. Transitional cell carcinoma (TCC) has been described as a primary ovarian carcinoma in which definite urothelial features are present, but no benign, metaplastic, and/or proliferating Brenner tumor can be identified. It accounts for 1 to 2% of all ovarian tumors. Bilateral involvement is still rare. It is reported to be chemosensitive and has better prognosis than other types of common epithelial tumors of the ovary. Here we report a rare case of bilateral TCC of the ovary managed by staging operation, followed by postoperative chemotherapy. How to cite this article Bannur HB, Suranagi VV, Davanagere R, Pilli GS. Bilateral Ovarian Transitional Cell Carcinoma. J South Asian Feder Obst Gynae 2017;9(2):195-196.